Food and Drug Administration

Advisory Committee for Reproductive Health Drugs

September 29, 2003


Gonadotropins in ART: Patterns of Use, Trends in Success Rates, and Assessing Efficacy Endpoints, Dr. Jim Toner, MD, PhD (HTM) (PPT)

Outcome Measurement for Assisted Reproductive Technology, Dr. David Keefe, MD, Tufts New England Medical Ctr. (HTM) (PPT)

Clinical Trials - Human Gonadotropin Drug Products--A Regulatory Perspective, Dr. Shelley Slaughter, MD, PhD, FDA (HTM) (PPT)